about
Activin A more prominently regulates muscle mass in primates than does GDF8.Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.ACVR1B rs2854464 Is Associated with Sprint/Power Athletic Status in a Large Cohort of Europeans but Not BraziliansTreatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass.Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.Activins in reproductive biology and beyond.Activins and Inhibins: Roles in Development, Physiology, and Disease.Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.
P2860
Q33630598-CDC742EA-0E30-4546-9476-114F1FCFDBCBQ34553410-5E5A3208-DBE0-4083-962C-95F3C9678F68Q36037930-7223C74D-8471-4528-8F7E-92B3ADFDE710Q36254527-2FE15486-36A6-40AA-AB3D-80EAC53B0844Q36363858-C6B13E6E-890B-4779-84EB-A6B9D43EDB13Q36890245-8B887D43-7610-4EFF-A146-9D01AE6966E7Q37555493-C87BDC6F-1F9D-4C65-A6F7-CF5379C41511Q38736689-D6B83C54-9DB4-4838-8480-24639B28720CQ38872337-93AE9652-AF1B-45F2-98F5-062EFB643D62Q40162611-24E0AB66-9655-4B10-9272-42BA1162236FQ41010363-46ECA083-98D9-4383-A566-2D4221CBA40E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of novel activin-targeted therapeutics.
@ast
Development of novel activin-targeted therapeutics.
@en
type
label
Development of novel activin-targeted therapeutics.
@ast
Development of novel activin-targeted therapeutics.
@en
prefLabel
Development of novel activin-targeted therapeutics.
@ast
Development of novel activin-targeted therapeutics.
@en
P2093
P2860
P50
P356
P1433
P1476
Development of novel activin-targeted therapeutics.
@en
P2093
Emily K Kelly
George Lovrecz
Justin L Chen
Kelly L Walton
Sara L Al-Musawi
P2860
P304
P356
10.1038/MT.2014.221
P577
2014-11-17T00:00:00Z